Conceptualising the Commercial Determinants of Health Using a Power Lens: A Review and Synthesis of Existing Frameworks

Benjamin Wood ¹ * , Phillip Baker ² , Gary Sacks ¹

Cited by CrossRef:

1- Bennett E, Topp S, Moodie A. National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis. Int J Health Policy Manag. 2023;12:6876 [Crossref]

2- Loewenson R, Godt S, Chanda-Kapata P. Asserting public health interest in acting on commercial determinants of health in sub-Saharan Africa: insights from a discourse analysis. BMJ Glob Health. 2022;7(7):e009271 [Crossref]

3- Patay D, Friel S, Schram A, Sell S. How do interests, ideas, and institutions affect multisectoral governance? The case of tobacco governance in two Pacific small island developing states. Regulation & Governance. 2023;17(2):313 [Crossref]

4- Edwards R, Hoek J, Karreman N, Gilmore A. Evaluating tobacco industry ‘transformation’: a proposed rubric and analysis. Tob Control. 2022;31(2):313 [Crossref]

5- Huse O, Reeve E, Zambrano P, Bell C, Peeters A, Sacks G, Baker P, Backholer K. Understanding the corporate political activity of the ultra - processed food industry in East Asia: a Philippines case study. Global Health. 2023;19(1) [Crossref]

6- Wood B, Karouzakis C, Sievert K, Gallasch S, Sacks G. Protecting whose welfare? A document analysis of competition regulatory decisions in four jurisdictions across three harmful consumer product industries. Global Health. 2024;20(1) [Crossref]

7- de Lacy-Vawdon C, Vandenberg B, Livingstone C. Recognising the elephant in the room: the commercial determinants of health. BMJ Glob Health. 2022;7(2):e007156 [Crossref]

8- Wood B, Williams O, Baker P, Nagarajan V, Sacks G. The influence of corporate market power on health: exploring the structure-conduct-performance model from a public health perspective. Global Health. 2021;17(1) [Crossref]

9- Freudenberg N, Lee K, Buse K, Collin J, Crosbie E, Friel S, Klein D, Lima J, Marten R, Mialon M, Zenone M. Defining Priorities for Action and Research on the Commercial Determinants of Health: A Conceptual Review. Am J Public Health. 2021;111(12):2202 [Crossref]

10- Robinson E, Parker C, Carey R, Foerster A, Blake M, Sacks G. Integrating nutrition and obesity prevention considerations into institutional investment decisions regarding food companies: Australian investment sector perspectives. Global Health. 2022;18(1) [Crossref]

11- Huse O, Reeve E, Bell C, Sacks G, Baker P, Wood B, Backholer K. Strategies used by the soft drink industry to grow and sustain sales: a case-study of The Coca-Cola Company in East Asia. BMJ Glob Health. 2022;7(12):e010386 [Crossref]

12- Burgess R, Nyhan K, Freudenberg N, Ransome Y. Corporate activities that influence population health: a scoping review and qualitative synthesis to develop the HEALTH-CORP typology. Global Health. 2024;20(1) [Crossref]

13- Lee K, Freudenberg N. Public Health Roles in Addressing Commercial Determinants of Health. Annu Rev Public Health. 2022;43(1):375 [Crossref]

14- McKevitt S, White M, Petticrew M, Summerbell C, Vasiljevic M, Boyland E, Cummins S, Laverty A, Junghans C, Millett C, De Vocht F, Hrobonova E, Vamos E. Typology of how ‘harmful commodity industries’ interact with local governments in England: a critical interpretive synthesis. BMJ Glob Health. 2023;8(1):e010216 [Crossref]

15- Wood B, Baker P, Scrinis G, McCoy D, Williams O, Sacks G. Maximising the wealth of few at the expense of the health of many: a public health analysis of market power and corporate wealth and income distribution in the global soft drink market. Global Health. 2021;17(1) [Crossref]

16- Crocetti A, Cubillo (Larrakia) B, Lock (Ngiyampaa) M, Walker (Yorta Yorta) T, Hill (Torres Strait Islander) K, Mitchell (Mununjali) F, Paradies (Wakaya) Y, Backholer K, Browne J. The commercial determinants of Indigenous health and well-being: a systematic scoping review. BMJ Glob Health. 2022;7(11):e010366 [Crossref]

Submit Your Paper Archive